REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 222 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7 | -50.0% | 2,763 | 0.0% | 0.00% | – |
| Q1 2024 | $14 | -86.4% | 2,763 | -76.5% | 0.00% | -100.0% |
| Q4 2023 | $103 | -28.5% | 11,761 | -6.5% | 0.00% | 0.0% |
| Q3 2023 | $144 | -54.7% | 12,583 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $318 | -13.6% | 12,583 | +10.3% | 0.00% | 0.0% |
| Q1 2023 | $368 | +49.6% | 11,412 | -14.5% | 0.00% | +50.0% |
| Q4 2022 | $246 | -99.9% | 13,346 | +15.0% | 0.00% | -33.3% |
| Q3 2022 | $313,000 | +104.6% | 11,607 | +5.0% | 0.00% | +200.0% |
| Q2 2022 | $153,000 | -31.4% | 11,052 | -3.3% | 0.00% | -50.0% |
| Q1 2022 | $223,000 | -44.8% | 11,428 | -53.7% | 0.00% | +100.0% |
| Q4 2021 | $404,000 | +15.8% | 24,708 | +97.1% | 0.00% | -66.7% |
| Q3 2021 | $349,000 | -11.2% | 12,536 | -5.4% | 0.00% | 0.0% |
| Q2 2021 | $393,000 | +73.1% | 13,255 | +63.2% | 0.00% | -66.7% |
| Q1 2021 | $227,000 | -9.2% | 8,120 | -7.9% | 0.01% | 0.0% |
| Q4 2020 | $250,000 | +13.1% | 8,815 | +0.4% | 0.01% | -10.0% |
| Q3 2020 | $221,000 | – | 8,776 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |